InvestorsHub Logo
Followers 42
Posts 5093
Boards Moderated 0
Alias Born 05/10/2012

Re: Butterfingers post# 32

Friday, 01/04/2013 4:39:32 PM

Friday, January 04, 2013 4:39:32 PM

Post# of 7490
The stock must trade 20:1 on the OTC, so the dollar value will always be balanced. They do get slightly off sometimes, but not much. If it is just as easy for you to buy on the ASX the better volume will make it easier for you to enter and exit your position in the short term. But if extra fees come into play then I don't think it's worth it.

I wouldn't be afraid of buying the AVMXY shares. The U.S. is where Biotech companies make it big and I think Avita is more interested in being something on the U.S. stock exchange. They have offices here now and they moved their Re-Cell manufacturing to the U.S. as well. They created the AVMXY shares solely to become more attractive to institutional investors.

Originally this stock traded on the same penny stock metric that the ASX did, but under the symbol AVMXF. They did away with that and BNY Mellon converted all the shares held for free over to AVMXY. This stock is valued on the low side of a pre-revenue company. And it actually has consistent revenue from it's respiratory products. The cash burn rate is pretty high right now but that is necessary. They have about 10 million in reserves and no debt, which is great.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News